Atlas Trials

Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)

Clinical trial NCT04410367 · COMPLETED

Trial details

NCT number
NCT04410367
Sponsor
Blue Earth Diagnostics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Metastases
Start date
2020-08-31
Primary completion
2021-12-31
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.